U.S. Food Stock News

Why Trip.com Group Is Back on Investor Radars Trip.com Group (TCOM) has been moving on mixed recent returns, with the share price up over the past month but lower over the past 3 months and year to date. Investors are weighing this performance against the company’s current earnings profile and valuation metrics. See our latest analysis for Trip.com Group. At a share price of $52.95, Trip.com Group’s recent 1 day and 7 day share price declines sit against a 30 day gain, while its 1 year total...

Blackstone (BX) has just laid out its latest scorecard, with Q4 2025 revenue at US$4.2b and basic EPS of US$1.30 setting the stage for how investors approach the Q1 2026 update. Over recent quarters, revenue has shifted from US$3.2b in Q1 2025 to US$4.2b in Q4 2025, while basic EPS has ranged from US$0.80 to US$1.30 across that period, and trailing 12 month net income reached US$3.0b on revenue of US$14.2b. With a trailing net profit margin of 21.2% and forecasts indicating faster revenue...

In recent days, Astera Labs drew fresh attention as analysts highlighted its upcoming first-quarter 2026 earnings release and its role in easing data center compute-to-data bottlenecks through products like Aries smart retimers and Scorpio smart fabric switches. This focus on critical AI data center connectivity, alongside expectations for broader PCIe Gen 6 adoption, is sharpening interest in how central Astera Labs could become within next-generation cloud infrastructure. With earnings...

Union Pacific (UNP) opened Q1 2026 earnings season with Q4 2025 revenue of US$6.1 billion and basic EPS of US$3.12, capping a trailing twelve month period in which EPS reached US$12.00 on revenue of US$24.5 billion and earnings grew 5.8% year over year. Over recent quarters, the company has seen revenue move in a tight range between US$6.0 billion and US$6.2 billion while quarterly basic EPS tracked between US$2.71 and US$3.16. This gives a clear view of how the earnings line has behaved...

Nano-X Imaging’s April 2026 update showed fourth-quarter 2025 sales rising to US$3.72 million while net loss widened to US$33.37 million, including a US$17.53 million impairment, alongside full-year 2025 losses and the appointment of incoming CFO Guy Nathanzon after Ran Daniel’s planned departure. At the same time, a new clinical collaboration with Meir Medical Center to further validate the Nanox.ARC system highlights management’s focus on strengthening the technology’s real-world...

If you are wondering whether American Electric Power Company at around US$135 a share still offers value, you will want to look closely at what the numbers are really saying about its price. Over the recent past, the stock has shown returns of 0.4% over 7 days, 4.9% over 30 days, 16.6% year to date, 30.8% over 1 year, 62.9% over 3 years and 83.9% over 5 years, which can change how investors think about both upside and risk. Recent coverage has focused on American Electric Power Company's...

If you are wondering whether Alaska Air Group at around US$41 per share still offers value, the next step is to look closely at what the current price implies about the business. The stock is flat over the last 7 days, up 7.0% over 30 days, but shows a 20.1% decline year to date and a 0.8% decline over the past year. This raises questions about how the market is reassessing its prospects and risk. Recent coverage of the US airline sector has focused on ongoing cost pressures, demand...

Cathay General Bancorp (CATY) opened 2026 with Q1 revenue of US$196.6 million and basic EPS of US$1.30, alongside net income of US$86.9 million. This followed a year in which trailing twelve month revenue reached US$769.6 million and EPS came in at US$4.86. Over the past year, revenue has moved from US$691.3 million to US$769.6 million on a trailing basis, while TTM EPS increased from US$3.97 to US$4.86. This gives investors a clearer view of how the latest quarter fits within a steadily...

Universal Technical Institute recently reported that new student enrollments have been weaker than anticipated and that it plans to step up investments to defend its position in technical education, a move expected to weigh on free cash flow margins. This combination of softer demand and rising investment needs has intensified questions about how effectively the company is deploying capital to support long-term performance. We’ll now examine how concerns over weaker new student enrollment...

Joby Aviation (NYSE:JOBY) is partnering with Reuben Brothers to build an air taxi vertiport and passenger lounge at Century Plaza in Los Angeles. The project marks Joby's first integration of an eVTOL vertiport directly into a residential development. The plan uses existing helipad infrastructure and adds a dedicated passenger lounge aimed at everyday urban users. Joby Aviation operates in the electric vertical take off and landing, or eVTOL, air taxi space, where companies are working to...

Sprinklr (NYSE:CXM) has launched its Spring 2026 Release, introducing advanced AI-driven features for its customer experience platform. The release adds autonomous agent evaluation tools designed to assess and monitor AI performance in customer service. Sprinklr also announced a new alliance with CreatorIQ to integrate creator intelligence with its unified social media management capabilities. Sprinklr enters this product release cycle with its shares at $4.84 and a value score of 2,...

Recent performance context for Campbell's Campbell's (CPB) has drawn attention after a period where the stock showed a small move over the past week, along with a sharper negative total return over the past 3 months and year. See our latest analysis for Campbell's. At a share price of $20.96, Campbell's recent 7 day and 30 day share price returns have been broadly flat, while the 90 day share price return of a 21.76% decline and 1 year total shareholder return of a 39.57% loss point to fading...

ZORYVE (roflumilast) cream has received a strong, high certainty recommendation in the American Academy of Dermatology’s new pediatric atopic dermatitis guidelines. This is the AAD’s first set of clinical practice guidelines focused on pediatric atopic dermatitis, giving the product formal visibility in a key treatment area. The endorsement supports ZORYVE’s role as an evidence backed option for long term use in children with atopic dermatitis. For Arcutis Biotherapeutics (NasdaqGS:ARQT),...

CME Group (NasdaqGS:CME) reported record average daily volumes and record revenues in Q1 2026. All six asset classes on the platform reached record activity levels in the quarter. The company is rolling out new options on Eris SOFR Swap futures and expanding Equity Index Dividend futures. Regulators approved an expanded cross margining arrangement with DTCC for U.S. Treasury and interest rate derivatives. CME Group sits at the center of global futures and options trading, connecting clients...

Heartland Express (HTLD) opened 2026 with Q1 results that extend a run of soft profitability, capped by trailing 12 month revenue of US$805.7 million and a basic EPS loss of US$0.67 tied to a net loss of US$52.5 million. Over the past six reported quarters, quarterly revenue has ranged from US$179.4 million to US$259.9 million, while basic EPS has moved between a loss of US$0.02 and a loss of US$0.25. This sets up a story where investors are weighing ongoing losses against forecasts that...

Shopify (SHOP) is back in focus as fresh commentary around its upcoming Q1 report highlights solid gross merchandise value trends, merchant growth, and heavier use of its tools, drawing renewed attention to the stock’s recent pullback. See our latest analysis for Shopify. At a share price of $124.23, Shopify has seen a 1-day share price return of 5.86% decline and a year to date share price return of 20.97% decline. However, the 1-year total shareholder return of 30.60% and 3-year total...

Martin Midstream Partners (MMLP) opened 2026 with Q1 results that keep the focus squarely on profitability, as the latest trailing 12 month figures show total revenue of US$716.1 million and a loss of US$14.4 million, or basic EPS of US$0.37. Over recent quarters, the partnership has seen quarterly revenue range from US$168.7 million to US$192.5 million, while basic EPS has moved between a profit of US$0.09 and losses of up to US$0.21. This sets up an earnings release where investors are...

Rezolve AI (RZLV) drew fresh attention after announcing its brainpowa commerce-tuned AI model suite is now available within Microsoft Foundry, giving brands access to commerce-focused copilots deployed directly on Microsoft Azure. See our latest analysis for Rezolve AI. Despite the Microsoft Foundry news and a last close of $2.60, Rezolve AI’s recent momentum has been mixed, with a 1-month share price return of 1.17% but a 90-day share price decline of 17.20%, alongside a 1-year total...

Lake Shore Bancorp (LSBK) has just wrapped up Q4 2025 with total revenue of US$7.3 million, basic EPS of US$0.26 and net income of US$1.9 million, while trailing twelve month figures show revenue of US$28.0 million and EPS of US$0.97, alongside 47.4% earnings growth over the past year. Over recent quarters, the company has seen revenue move from US$6.4 million and EPS of US$0.17 in Q3 2024 to US$7.7 million and EPS of US$0.32 in Q3 2025, before settling at Q4 2025 levels. This progression...

Origin Bancorp (OBK) has just posted Q1 2026 results with revenue of US$99.1 million and Basic EPS of US$0.89, setting the tone for how the year is starting after a run of solid quarterly contributions to trailing 12 month EPS of US$2.60 and net income of US$80.5 million. Over recent quarters, revenue has moved from US$83.4 million in Q4 2024 to US$90.6 million in Q1 2025 and US$99.8 million in Q4 2025. Quarterly Basic EPS has ranged from US$0.46 to US$0.95 across that same stretch, giving a...

Inhibrx Biosciences recently reported updated interim Phase 1/2 data showing that ozekibart (INBRX-109) plus FOLFIRI achieved a 20% objective response rate, 87% disease control rate, and manageable safety in heavily pretreated patients with unresectable colorectal cancer, while also advancing a Biologics License Application for ozekibart in conventional chondrosarcoma. These data position ozekibart as a potential first-in-class DR5 agonist with activity across multiple hard-to-treat solid...

Popular (BPOP) has just posted another solid quarter, with Q4 2025 revenue of US$751.8 million and basic EPS of US$3.54, setting the tone as investors look at the new Q1 2026 reporting period. The bank has seen quarterly revenue move from US$689.4 million in Q4 2024 to US$751.8 million in Q4 2025, while basic EPS over that same stretch climbed from US$2.51 to US$3.54, giving you a clear sense of how the income line has scaled alongside the top line. Taken together with an improved net profit...

Katahdin Bankshares (KTHN) has just put another quarter on the board, with Q4 2025 revenue of US$11.9 million and basic EPS of US$0.99 setting the tone after a year in which trailing net income reached US$10.7 million on revenue of US$44.3 million. Over recent periods the company has seen revenue move from US$9.5 million and EPS of roughly US$0.56 in Q4 2024 to US$11.9 million and US$0.99 respectively in Q4 2025. Trailing basic EPS for the last reported twelve months reached about US$3.37...

American Riviera Bancorp (ARBV) opened 2026 with Q1 results that build on a solid finish to last year, with Q4 2025 revenue at about US$14.4 million and basic EPS of roughly US$0.80, while trailing twelve month revenue stood at about US$50.4 million and EPS at roughly US$2.18. Over recent quarters, revenue has moved from about US$10.7 million in Q4 2024 to US$14.4 million in Q4 2025, and basic EPS has shifted from roughly US$0.35 to US$0.80. This sets up a story where higher net income and...